Table 3 |
|||||
|
Overview of available disease burden estimates attributable to chemicals |
|||||
|
Chemicals/Groups of chemicals |
Disease outcomes considered (attributable fraction) |
Deaths |
DALYs‡ |
Main limitations¤ |
Data year/method§ |
|
|
|||||
|
Chemicals in acute poisonings |
526,000 (sub-total) |
9,666,000 (sub-total) |
|||
|
|
|||||
|
Chemicals (including drugs) involved in unintentional acute poisonings (methanol, diethylene glycol, kerosene, pesticides etc.) |
Unintentional poisonings (71%) |
240,000a |
5,246,000a |
Limited to preventable poisonings. Total unintentional poisonings would amount to 346,000 deaths and 7,445,000 DALYs[12] |
2004; C [13]b |
|
|
|||||
|
Chemicals involved in unintentional occupational poisonings |
Unintentional poisonings (occupational) (8.6%) |
30,000c |
643,000c |
- |
2004; A [14] |
|
|
|||||
|
Pesticides pesticides involved in self-inflicted injuries |
Self-inflicted injuries (23%) |
186,000 |
4,420,000 |
Limited to preventable self inflicted injuries. Impact of accidental and chronic exposures not considered. |
2002; C [13] |
|
|
|||||
|
Chemicals in occupational exposures (longer term effects) |
581,000 (sub-total) |
6,763,000 (sub-total) |
|||
|
|
|||||
|
Asbestos |
Malignant mesothelioma (NA); trachea, bronchus, lung cancer (0.3%); asbestosis (NA) |
107,000d |
1,523,000d |
- |
|
|
|
|||||
|
Occupational lung carcinogens (arsenic, asbestos, beryllium, cadmium, chromium, diesel exhaust, nickel, silica) |
Trachea, bronchus, lung cancer (8.6%) |
111,000 |
1,011,000 |
Only 8 of the chemicals or chemical mixtures classified as carcinogenic or probably carcinogenic to humans taken into account |
2004; A [14] |
|
|
|||||
|
Occupational leukaemogens (benzene, ethylene oxide, ionizing radiation) |
Leukaemia (2.3%) |
7,400e |
113,000e |
Only 2 of the chemicals or chemical mixtures classified as carcinogenic or probably carcinogenic to humans taken into account |
2004; A [14] |
|
|
|||||
|
Occupational particulates - causing COPD (dusts, fumes/gas) |
COPD (13%) |
375,000f |
3,804,000f |
- |
2004; A [14] |
|
|
|||||
|
Occupational particulates - other respiratory diseases than COPD (silica, asbestos and coal mine dust) |
Asbestosis (NA); silicosis (NA); pneumoconiosis (NA) |
29,000 |
1,062,000 |
- |
2004; A [14] |
|
|
|||||
|
Air pollutant mixtures |
3,720,000 (sub-total) |
60,669,000 (sub-total) |
|||
|
|
|||||
|
Outdoor air pollutants (particulate matter, sulfur dioxide, nitrogen oxides, benzo[a]pyrene, benzene, others) |
Lung cancer (7.9%); acute respiratory infections (1.6%); selected cardiopulmonary diseases (3.4%) |
1,152,000 |
8,747,000 |
Only urban air pollution in cities with >100 000 inhabitants taken into account. Health impact from rural air pollution unknown. |
2004; A [14] |
|
|
|||||
|
Outdoor air pollutants emitted from ships (particulate matter, sulfur dioxide, nitrogen oxides, benzo[a]pyrene, benzene, others) |
Lung cancer (0.3%); selected cardiopulmonary diseases (0.4%) |
60,000g |
NA |
- |
2002; B [95] |
|
|
|||||
|
Indoor air pollutants from solid fuel combustion (carbon monoxide, nitrogen oxides, sulfur oxides, benzene, formaldehyde, polyaromatic compounds, particulates, others) |
Lung cancer (2.9%); acute respiratory infections (33%); COPD (33%) |
1,965,000 |
41,009,000 |
Disease burden from emissions from building materials and household products is not know. BoD from second hand smoke has been evaluated separately. |
2004; A [14] |
|
|
|||||
|
Second-hand smoke (nicotine, formaldehyde, carbon monoxide, phenols, nitrogen oxides, naphthalenes, tar, nitrosamine, PAHs, vinyl chloride, various metals, hydrogen cyanide, ammonia, others) |
Lower respiratory infections (6.3%); otitis (1.7%); asthma (11%); lung cancer (1.8%); ischaemic heart disease (4.5%) |
603,000 |
10,913,000 |
- |
2004; B [29] |
|
|
|||||
|
Single chemicals with mostly longer term effects |
152,000 (sub-total) |
9,102,000 (sub-total) |
|||
|
|
|||||
|
Lead |
Mild mental retardation; Cardiovascular diseases |
143,000 |
8,977,000 |
- |
2004; A [14] |
|
|
|||||
|
Arsenic in drinking-water |
Diabetes mellitus (0.04%) ischemic heart disease (0,11%); lung cancer (0.25%); bladder cancer (1.2%); kidney cancer (NA); skin cancer (0.30%) |
9,100a |
125,000a |
Limited to exposure through drinking water. Limited to Bangladesh. |
2001; B [11] |
|
|
|||||
|
Total #,h Total in children <15 years |
All considered diseases |
4,879,000 (8.3%) 1,073,000 (22%) |
86,200,000 (5.7%) 46,627,000 (54%) |
Mainly 2004; A |
|
|
|
|||||
|
‡ DALYs are "Disability-adjusted life years", a weighted measure of years of life lost due to premature death, and years lived with disability. ¤ Only outcomes qualified as strong evidence were considered. § Methods: A: Comparative Risk Assessment (CRA); B: Based on exposure and exposure-response (similar to CRA); C: Evidence synthesis and expert evaluation. # The estimates were developed within three years and their pooling is unlikely to introduce a significant error. NA: not available. -: none. a Estimate not compared to counterfactual exposure, which is however estimated to be negligible using a theoretical minimum exposure given available management options for concerned chemicals. b Values updated for 2004 based on original reference. c Already included in total unintentional acute poisonings and therefore not included again in the total. d Lung cancer and asbestosis caused by asbestos are also considered in occupational lung carcinogens and particulates and this part of the burden is therefore not counted twice in the total. e Also includes a small fraction of leukaemia caused by ionizing radiation. f Parts of the particulates are organic in nature, and the estimate therefore includes a small fraction that is not or not directly related to chemicals g Overlaps with the burden from outdoor air pollution and is therefore not included in the total. h Total is corrected for double counting (chemicals considered in more than one estimate); not all disease burdens are however additive, and joint exposures could lead to slight overestimate (see Methods section). |
|||||
|
Prüss-Ustün et al. Environmental Health 2011 10:9 doi:10.1186/1476-069X-10-9 |
|||||